6899 studies found for:    insulin
Show Display Options
Rank Status Study
1 Completed Topic Insulin Accelerates Wound Healing in Diabetes
Conditions: Diabetes Mellitus;   Wounds
Intervention: Drug: topic cream insulin
2 Completed
Has Results
Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro Alone
Condition: Diabetes Mellitus
Interventions: Drug: Insulin Lispro;   Drug: Regular Human Insulin;   Drug: rHuPH20
3 Recruiting Regulation of Endogenous Glucose Production by Brain Insulin Action
Condition: Insulin Resistance, Diabetes
Intervention: Drug: Intranasal insulin
4 Completed
Has Results
U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod
Conditions: Type 2 Diabetes;   Insulin Resistance
Intervention: Drug: U-500 Insulin delivered by Omnipod (disposable insulin pump)
5 Enrolling by invitation Comparison Study of Insulin Glargine and NPH Insulin
Condition: Diabetes
Interventions: Drug: Switching to NPH insulin;   Drug: Continuation of insulin glargine
6 Completed Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Long-acting bedtime insulin detemir (Levemir);   Drug: Insulin detemir and pre-meal insulin aspart.
7 Completed
Has Results
Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Lispro Low Mixture (LM);   Drug: Insulin Glargine;   Drug: Prandial Insulin Lispro
8 Terminated Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents
Condition: Diabetes Type 1
Interventions: Drug: insulin Glargine + Insulin Apidra;   Drug: Insulin NPH + Insulin Apidra: Active Comparator
9 Completed
Has Results
Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Humalog;   Drug: Humulin-R;   Drug: Recombinant human hyaluronidase PH20 (rHuPH20)
10 Recruiting Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Total Parenteral Nutrition
Condition: Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition
Interventions: Drug: Glargine Insulin;   Drug: Regular insulin
11 Completed
Has Results
Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin Lispro;   Drug: Insulin Aspart
12 Completed
Has Results
Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: biphasic insulin aspart;   Drug: insulin detemir;   Drug: insulin aspart
13 Unknown  The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
Condition: Diabetes
Interventions: Drug: central insulin;   Drug: Placebo
14 Recruiting Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
Condition: Diabetes During Pregnancy
Interventions: Drug: NPH;   Drug: Insulin LISPRO;   Drug: Insulin glulisine
15 Completed
Has Results
Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin lispro 2 day reservoir in-use;   Drug: Insulin lispro 6 day reservoir in-use;   Drug: Insulin aspart 6 day reservoir in-use
16 Completed A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Insulin Aspart, BIAsp 70, BIAsp50, Human Insulin
17 Completed
Has Results
Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Detemir + aspart insulin before meals;   Drug: NPH insulin + regular insulin
18 Completed
Has Results
Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin Lispro 6 Day (6D);   Drug: Insulin Aspart 6 Day (6D)
19 Completed Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes
Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Drug: Detemir;   Other: Novolin NPH or Humulin N
20 Terminated Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine
Conditions: Diabetes;   Obesity
Interventions: Drug: insulin Levemir;   Drug: insulin Lantus

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years